MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,275,000 | -20.6% | 100,790 | -41.4% | 0.36% | -20.7% |
| Q1 2016 | $7,907,000 | -8.0% | 171,956 | -3.3% | 0.45% | +18.7% |
| Q4 2015 | $8,595,000 | -0.7% | 177,801 | -12.7% | 0.38% | -16.9% |
| Q3 2015 | $8,654,000 | -30.1% | 203,628 | +87.9% | 0.46% | -10.6% |
| Q2 2015 | $12,373,000 | -15.7% | 108,346 | -4.7% | 0.51% | -11.9% |
| Q1 2015 | $14,679,000 | +15.7% | 113,730 | -10.7% | 0.58% | +8.6% |
| Q4 2014 | $12,692,000 | -17.7% | 127,420 | -18.4% | 0.53% | -17.4% |
| Q3 2014 | $15,429,000 | -11.3% | 156,058 | -30.9% | 0.64% | -4.3% |
| Q2 2014 | $17,397,000 | +24.2% | 225,696 | +3.7% | 0.67% | +26.7% |
| Q1 2014 | $14,004,000 | -3.8% | 217,557 | -4.6% | 0.53% | +1.5% |
| Q4 2013 | $14,561,000 | -10.1% | 228,158 | -15.6% | 0.52% | -22.0% |
| Q3 2013 | $16,196,000 | – | 270,204 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |